The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 22.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 64%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (22 analysts) rates it buy, with a mean price target of $51.
Globant S.A.
GLOB · the NYSE · USD · Market cap $1.7B · 28,510 employees
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 08:38 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Globant S.A. holds its Distribution at $39.13. Consolidating, no directional conviction, held for 6 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 6 days |
| Price at the screen | $39.13 |
| Valuation | 15.29 trailing · 6.31 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.98 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 35.59% | Below 33% | Interest-bearing debt is 35.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 17.01% | Below 33% | Cash held in interest-bearing accounts and securities is 17.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 44% discount to our $56.25 fair value, weak competitive moat.
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 43.8% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +15% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGlobant trades cheap but debt kills the case
Picture a software shop promising AI magic while its balance sheet quietly creaks under too much borrowed money. Globant fails our ethical screen on debt ratio, and that single red flag overrides the headline numbers. Forward earnings sit at just 4.9 times, yet revenue shrank 1 percent last year, margins scrape 4 percent and return on equity limps along at 5 percent with a weak competitive moat.
We pass because an ethical breach is non-negotiable regardless of the 94 percent gap between the $32.23 share price and our $62.50 fair value. Twenty-two analysts still say buy with a $50 median target, but the business shows no durable edge and the debt load sits outside our tolerance.
Risk sits mainly in the leverage and the lack of growth, which together turn a low multiple into a warning rather than a bargain. Analysis, not advice.
| Forward P/E | 6.3xvery cheap relative to earnings |
| Trailing P/E | 15.3xreasonably valued |
| EPS, trailing | 2.56 |
| EPS, forward | 6.21 |
| Revenue growth | +0.0%revenue is shrinking |
| Profit margin | 4.6%barely profitable |
| Return on equity | 5.5%a modest return on shareholder capital |
| Debt to equity | 0.24minimal debt: a conservative balance sheet |
| Current ratio | 1.84healthy short-term liquidity |
| Beta | 0.98steadier than the market |
| Short interest, float | 0.18% |
| 52-week range | 27.56 - 72.10 |
| Moat | WEAK |
| Market cap | $1.7B |
| Employees | 28,510 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Luxembourg and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGLOB trades on the NYSE (the company is based in Luxembourg). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 64%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (23 analysts) rates it buy, with a mean price target of $62.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 64%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (23 analysts) rates it buy, with a mean price target of $62.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 Apr2025 | John Boozman | Republican | buy | 1K–15K |
| 8 Apr2025 | John Boozman | Republican | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $37.21 | -1.4% | · | $986 | -1.4% |
| 2 months | $43.26 | -15.2% | · | $848 | -15.2% |
| 3 months | $45.23 | -18.9% | · | $811 | -18.9% |
| 6 months | $67.88 | -46.0% | · | $540 | -46.0% |
| 1 year | $103.28 | -64.5% | · | $355 | -64.5% |
| 2 years | $154.48 | -76.3% | · | $237 | -76.3% |
| 3 years | $178.53 | -79.5% | · | $206 | -79.5% |
| 5 years | $218.08 | -83.2% | · | $168 | -83.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GLOB does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.